Neurointerventional devices,
neurostimulation devices, cranial dopplers, electromyographs, implantable
neurostimulators, neurosurgery surgical robots, and skull clamps are some of
the most widely used neurology devices.
Statistics:
The global Neurology
Devices Market is estimated to account for US$ 44,045.9 Mn in terms of
value by the end of 2027.
Global Neurology Devices Market:
Drivers
R&D of new neurology devices
is expected to propel growth of the global neurology devices market over the
forecast period. For instance, in March 2020, researchers at the Institute for
Genomic Medicine at Columbia University Irving Medical Center reported
development of enhancement-mode ion-based transistor designed to record the
electrical activity of neurons and to perform real-time calculations that help
in identifying and monitoring neurological disorders.
Global Neurology Devices Market:
Opportunities
Development of novel imaging
software for neurological disorders is expected to offer lucrative growth
opportunities for players in the global neurology devices market. For instance,
in February 2020, Qynapse, a France-based medical technology company, received
510(k) clearance from the U.S. Food and Drug Administration for its QyScore
neurodegenerative disease imaging software.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3889
Global Neurology Devices Market:
Restraints
Product recalls are expected to
hamper the market growth. For instance, in November 2019, The U.S. Food and
Drug Administration (FDA) issued a class 1 recall for Zimmer Biomet’s ROSA
Brain device, citing a software issue.
Key Takeaways:
The global neurology devices
market was valued at US$ 13,572.1 Mn in 2019 and is forecast to reach a value
of US$ 44,045.9 Mn by 2027 at a CAGR of 15.9% between 2020 and 2027. Increasing
R&D of new neurology devices is expected to propel growth of the global
neurology devices market over the forecast period.
Neuro-stimulation Devices segment
held dominant position in the global neurology devices market in 2019,
accounting for 71.4% share in terms of value, followed by Interventional
Neurology Devices and CSF Management devices, respectively. Increasing
prevalence of neurological disorders is expected to propel growth of the segment
during the forecast period.
Market Trends
Major players in the market are
donating neurology devices to aid healthcare systems during Covid-19 pandemic.
For instance, in May 2020, BIONIK Laboratories Corp. donated an InMotion
robotic system, used to help stroke survivors and those with other neurological
conditions regain arm movement, to Einstein Healthcare Network's MossRehab, an
independent medical center in Philadelphia, U.S.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/neurology-devices-market-3889
Major players in the market are
focused on approval and launch of new devices to expand their product
portfolio. For instance, in February 2020, Avanos Medical, Inc. received the
U.S. Food and Drug Administration (FDA) approval for its 80-Watt COOLIEF Radiofrequency
(RF) system for neurological lesion procedures.
Global Neurology Devices Market:
Competitive Landscape
Major players operating in the
global neurology devices market include, B. Braun Melsungen AG, Boston
Scientific Corporation, BIONIK Laboratories Corp., Integra LifeSciences
Holdings Corporation, Johnson and Johnson, Magstim Co Ltd., Braintale SAS,
Medtronic, plc., Abbott, Zimmer Biomet, Stryker Corporation, Helius Medical
Technologies, Inc., Avanos Medical, Inc., W.L. Gore & Associates, Inc.,
HeadsafeIP Pty Ltd., Cerus Endovascular Ltd., and Cyberonics, Inc.
Global Neurology Devices Market:
Key Developments
May 2020: HeadsafeIP Pty Ltd., a
privately held brain health technology company, received 510(k) clearance from
the U.S. Food and Drug Administration (FDA) for its NUROCHEK system for brain
assessment
April 2020: Cerus Endovascular
Ltd. received CE Mark approval for its 021 Contour Neurovascular System,
compatible with smaller commercially available 021 microcatheters for the
treatment of saccular intracranial aneurysms
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3889
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment